Scholars@Duke publication: Therapy and clinical trials.

Therapy and clinical trials.

Publication , Journal Article

Sodhi, N; Krasuski, RA

Published in: Curr Opin Lipidol

June 2013

Published version (DOI) Open Access Copy (Duke) Link to item

Duke Scholars

Author Richard Andrew Krasuski Medicine, Cardiology

Published In

Curr Opin Lipidol

DOI

10.1097/MOL.0b013e3283616351

EISSN

1473-6535

Publication Date

June 2013

Volume

Issue

Start / End Page

281 / 282

Location

England

Related Subject Headings

Serine Endopeptidases
Proprotein Convertases
Proprotein Convertase 9
Oligonucleotides
Niacin
Hyperlipoproteinemia Type II
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Humans
Drug Administration Schedule
Drug Administration Routes

Citation

APA

Chicago

ICMJE

MLA

NLM

Sodhi, N., & Krasuski, R. A. (2013). Therapy and clinical trials. Curr Opin Lipidol, 24(3), 281–282. https://doi.org/10.1097/MOL.0b013e3283616351

Sodhi, Nishtha, and Richard A. Krasuski. “Therapy and clinical trials.” Curr Opin Lipidol 24, no. 3 (June 2013): 281–82. https://doi.org/10.1097/MOL.0b013e3283616351.

Sodhi N, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2013 Jun;24(3):281–2.

Sodhi, Nishtha, and Richard A. Krasuski. “Therapy and clinical trials.” Curr Opin Lipidol, vol. 24, no. 3, June 2013, pp. 281–82. Pubmed, doi:10.1097/MOL.0b013e3283616351.

Sodhi N, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2013 Jun;24(3):281–282.

Published In

Curr Opin Lipidol

DOI

10.1097/MOL.0b013e3283616351

EISSN

1473-6535

Publication Date

June 2013

Volume

Issue

Start / End Page

281 / 282

Location

England

Related Subject Headings

Serine Endopeptidases
Proprotein Convertases
Proprotein Convertase 9
Oligonucleotides
Niacin
Hyperlipoproteinemia Type II
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Humans
Drug Administration Schedule
Drug Administration Routes